Lynwood Capital Management Inc. bought a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, HoldingsChannel.com reports. The firm bought 31,454 shares of the company's stock, valued at approximately $315,000.

Several other institutional investors have also made changes to their positions in IQMD. Dupont Capital Management Corp acquired a new stake in shares of Intelligent Medicine Acquisition during the 4th quarter valued at about $255,000. Wolverine Asset Management LLC acquired a new position in Intelligent Medicine Acquisition in the fourth quarter valued at about $99,000. Radcliffe Capital Management L.P. acquired a new position in Intelligent Medicine Acquisition in the fourth quarter valued at about $2,970,000. Starboard Value LP acquired a new position in Intelligent Medicine Acquisition in the fourth quarter valued at about $952,000. Finally, Saba Capital Management L.P. acquired a new position in Intelligent Medicine Acquisition in the fourth quarter valued at about $15,539,000. 25.60% of the stock is currently owned by institutional investors and hedge funds.

Intelligent Medicine Acquisition Stock Performance

NASDAQ:IQMD opened at $10.05 on Friday. Intelligent Medicine Acquisition Corp. has a 12 month low of $9.86 and a 12 month high of $10.93. The company's 50-day moving average price is $10.00 and its two-hundred day moving average price is $9.97.

Intelligent Medicine Acquisition Profile

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.

Further Reading

• Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
• Procter's Earnings Start To Show Weakness In Q4
• MarketBeat: Week in Review 7/25 – 7/29
• The One Question You Have to Ask Before Investing in INTC Stock
• Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
• Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?

Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.